TW202339711A - 預防或治療心血管疾病的高穿透性的阿司匹靈和其他非類固醇抗發炎藥的前藥 - Google Patents

預防或治療心血管疾病的高穿透性的阿司匹靈和其他非類固醇抗發炎藥的前藥 Download PDF

Info

Publication number
TW202339711A
TW202339711A TW112101788A TW112101788A TW202339711A TW 202339711 A TW202339711 A TW 202339711A TW 112101788 A TW112101788 A TW 112101788A TW 112101788 A TW112101788 A TW 112101788A TW 202339711 A TW202339711 A TW 202339711A
Authority
TW
Taiwan
Prior art keywords
substituted
unsubstituted
acid
hydrochloride
diethylamino
Prior art date
Application number
TW112101788A
Other languages
English (en)
Chinese (zh)
Inventor
崇曦 于
徐麗娜
Original Assignee
大陸商蘇州泰飛爾醫藥有限公司
美商泰飛爾有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 大陸商蘇州泰飛爾醫藥有限公司, 美商泰飛爾有限公司 filed Critical 大陸商蘇州泰飛爾醫藥有限公司
Publication of TW202339711A publication Critical patent/TW202339711A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/603—Salicylic acid; Derivatives thereof having further aromatic rings, e.g. diflunisal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/625—Salicylic acid; Derivatives thereof having heterocyclic substituents, e.g. 4-salicycloylmorpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TW112101788A 2022-01-17 2023-01-16 預防或治療心血管疾病的高穿透性的阿司匹靈和其他非類固醇抗發炎藥的前藥 TW202339711A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
WOPCT/CN2022/072270 2022-01-17
CN2022072270 2022-01-17

Publications (1)

Publication Number Publication Date
TW202339711A true TW202339711A (zh) 2023-10-16

Family

ID=87280122

Family Applications (1)

Application Number Title Priority Date Filing Date
TW112101788A TW202339711A (zh) 2022-01-17 2023-01-16 預防或治療心血管疾病的高穿透性的阿司匹靈和其他非類固醇抗發炎藥的前藥

Country Status (10)

Country Link
US (1) US20250099491A1 (cg-RX-API-DMAC7.html)
EP (1) EP4465993A4 (cg-RX-API-DMAC7.html)
JP (1) JP2025504447A (cg-RX-API-DMAC7.html)
KR (1) KR20250005055A (cg-RX-API-DMAC7.html)
CN (1) CN118632699A (cg-RX-API-DMAC7.html)
AU (1) AU2023206720A1 (cg-RX-API-DMAC7.html)
CA (1) CA3252370A1 (cg-RX-API-DMAC7.html)
IL (1) IL314290A (cg-RX-API-DMAC7.html)
TW (1) TW202339711A (cg-RX-API-DMAC7.html)
WO (1) WO2023134732A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118373749A (zh) * 2024-04-29 2024-07-23 四川施成收生态科技有限公司 一种含有2-羟基苯甲酸-2-(二乙氨基)乙酯结构的化合物制备及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH399486A (fr) 1962-10-02 1965-09-30 Biosedra Lab Procédé de préparation de nouvelles salicylamides
AU2006346195B2 (en) 2006-07-09 2013-03-07 Techfields Biochem Co. Ltd Positively charged water-soluble prodrugs of aspirin
CN101500983B (zh) 2006-07-26 2015-09-16 于崇曦 具有快速皮肤穿透速度的带正电荷的水溶性二氟尼柳及相关化合物的前药
HK1207562A1 (en) 2012-01-18 2016-02-05 苏州泰飞尔医药有限公司 High penetration prodrug compositions and pharmaceutical composition thereof for treatment of pulmonary conditions
BR112015022896B1 (pt) * 2013-03-15 2022-08-23 Chongxi Yu Composto de fármacos de alta penetração, composição farmacêutica e seus usos para o tratamento de doenças de parkinson

Also Published As

Publication number Publication date
EP4465993A4 (en) 2026-01-07
CA3252370A1 (en) 2023-07-20
EP4465993A1 (en) 2024-11-27
JP2025504447A (ja) 2025-02-12
WO2023134732A9 (en) 2024-08-08
CN118632699A (zh) 2024-09-10
AU2023206720A1 (en) 2024-08-29
WO2023134732A1 (en) 2023-07-20
US20250099491A1 (en) 2025-03-27
IL314290A (en) 2024-09-01
KR20250005055A (ko) 2025-01-09

Similar Documents

Publication Publication Date Title
CN105143174B (zh) 治疗帕金森疾病的新型高穿透力药物及其药物组合物
TW202023623A (zh) 孟魯司特與肽的新共軛物
CN114423439B (zh) Nmn用于预防和/或治疗疼痛的用途及相应组合物
TWI913236B (zh) 新多功能寡肽
TW202120523A (zh) 新肽
SK16582002A3 (sk) Liečivé produkty s cikatrizačným účinkom obsahujúce biguanidové deriváty
TW202128729A (zh) 新肽及其在炎症治療中的用途
CN101522692A (zh) 具有快速皮肤穿透速度的带正电荷的水溶性的昔康及其相关化合物的前药
CA3211907A1 (en) New peptide conjugates
US20250099491A1 (en) Prevention or treatment of cardiovascular diseases with high penetration prodrugs of aspirin and other nsaids
ES2237625T3 (es) Uso de un derivado de hidantoina en una composicion farmaceutica contra la hipoalbuminemia.
US20220105082A1 (en) New formulations containing leukotriene receptor antagonists
TW202502805A (zh) 新多功能寡肽
US9364510B2 (en) Botanical composition and methods of manufacture and use
JP2009500364A (ja) 創傷治癒を促進するための可溶性グアニル酸シクラーゼ活性化剤の使用
CN106946866A (zh) 一种预防和治疗脑卒中的药物及其制备方法
JP7418502B2 (ja) 非常に速い皮膚及び膜浸透速度を有するnsaiaプロドラッグ及びその新規医薬使用
JP6621775B2 (ja) 非常に速い皮膚及び膜浸透速度を有するnsaiaプロドラッグ及びその新規医薬使用
CN110279691A (zh) 一种外科术后护理镇痛药物及其用途
HK40114947A (en) Wound treatment composition
TW202535906A (zh) 新型短鏈肽及其衍生物
CN106265112A (zh) 促进伤口愈合的药物、化妆用组合物和食品添加剂
HK40082364A (en) Topical formulations comprising combinations of montelukast and mussel adhesion proteins
WO2025077888A1 (zh) 一种适合外用的化合物及药物组合物
CN117860725A (zh) 一种神经保护素d1在作为和/或制备缓解骨癌痛药物中的应用